O. González-Llano

发表

Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide in children and adolescents with hematological malignancies

G. Ruiz-Argüelles, D. Gómez-Almaguer, Ó. González-Llano, 2016, Pediatric blood & cancer.

Acute lymphoblastic leukemia of childhood presenting as aplastic anemia: report of two cases

L. Villarreal-Martínez, D. Gómez-Almaguer, J. Jaime-Pérez, 2012, Revista brasileira de hematologia e hemoterapia.

Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial.

L. Villarreal-Martínez, D. Gómez-Almaguer, J. Jaime-Pérez, 2014, Cytotherapy.

Pain assessment of non-verbal patients undergoing bone marrow aspirations and lumbar puncture: Preliminary results

I. Velasco-Ruiz, Ó. González-Llano, C. Mancías-Guerra, 2021, Revista Medicina Universitaria.

Matched sibling donors versus alternative donors in allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia in México

A. Olaya-Vargas, M. Pérez-García, G. Ruiz-Argüelles, 2015, Hematology.

Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience.

G. Ruiz-Argüelles, D. Gómez-Almaguer, B. López-Martínez, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Circulating microRNA expression profile in B-cell acute lymphoblastic leukemia.

A. Hidalgo-Miranda, R. Ortíz-López, A. Rojas-Martínez, 2015, Cancer biomarkers : section A of Disease markers.

Serendipitous Improvement of Schizophrenia after Stem Cell Transplant for Hodgkin’s Lymphoma

Ó. González-Llano, Garza, Saucedo-Uribe, 2018 .

Haploidentical Bone Marrow Transplantation in 2015 and Beyond

G. Ruiz-Argüelles, D. Gómez-Almaguer, Ó. González-Llano, 2015, Current Oncology Reports.

More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura

L. Villarreal-Martínez, D. Gómez-Almaguer, J. Jaime-Pérez, 2016, Hematology.

Evaluation of hemoglobin performance in the assessment of iron stores in feto-maternal pairs in a high-risk population: receiver operating characteristic curve analysis

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2015, Revista brasileira de hematologia e hemoterapia.

Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3–CD19 depletion

L. Villarreal-Martínez, D. Gómez-Almaguer, J. Jaime-Pérez, 2014, Hematology.

Identification of Differentially Expressed Genes Associated with Prognosis of B Acute Lymphoblastic Leukemia

A. Hidalgo-Miranda, M. Martinez-Fierro, Á. Lugo‐Trampe, 2015, Disease markers.

Outpatient low toxic regimen with bortezomib in relapsed/refractory acute lymphoblastic leukemia in pediatrics and AYA patients: Single‐center Mexican experience

D. Gómez-Almaguer, Ó. González-Llano, Valentine Jiménez-Antolinez, 2020, Pediatric blood & cancer.

Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease.

S. Giralt, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease

Manuel Solano-Genesta, D. Gómez-Almaguer, J. Jaime-Pérez, 2012, Haematologica.

Low incidence and severity of graft‐versus‐host disease after outpatient allogeneic peripheral blood stem cell transplantation employing a reduced‐intensity conditioning

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2011, European journal of haematology.

Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2010, Annals of Hematology.

Subcutaneous alemtuzumab plus cyclosporine for the treatment of aplastic anemia

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2010, Annals of Hematology.

Results of an outpatient‐based stem cell allotransplant program using nonmyeloablative conditioning regimens

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2001, American journal of hematology.

Allogeneic peripheral blood stem cell transplantation using reduced‐intensity conditioning in an outpatient setting in ABO‐incompatible patients: are survival and graft‐versus‐host disease different?

D. Gómez-Almaguer, J. Jaime-Pérez, Ó. González-Llano, 2014, Transfusion.

Rituximab desensitization in pediatric acute lymphoblastic leukemia with severe anaphylaxis

Ó. González-Llano, Rosalaura V Villarreal-González, Sandra N González-Díaz, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases

G. Ruiz-Argüelles, D. Gómez-Almaguer, Ó. González-Llano, 2000, Bone Marrow Transplantation.

Mucopolysaccharidosis Type I in Mexico: Case-Based Review

Ó. González-Llano, René Gómez-Gutiérrez, C. Cantú-Reyna, 2023, Children.

Lesson learned in pediatric haploidentical transplantation in a low-resource environment: delivering melphalan IV and using low dose radiation reduce graft failure.

D. Gómez-Almaguer, Valentine Jiménez-Antolinez, A. Gómez-De León, 2024, Hematology.

Long-Term Insulin Independence in Type 1 Diabetes Mellitus Using a Simplified Autologous Stem Cell Transplant.

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2016, The Journal of clinical endocrinology and metabolism.

Allogeneic Hematopoietic Stem Cell Transplantation with Non-Myeloablative Conditioning in Patients with Acute Myelogenous Leukemia Eligible for Conventional Allografting: A Prospective Study

J. Vela-Ojeda, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2004, Leukemia & lymphoma.

Cyclosporine A for the Prevention of Ocular Graft versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients Is Safe and Feasible

D. Gómez-Almaguer, J. Jaime-Pérez, David Mauricio Martínez-Garza, 2019, Acta Haematologica.

Cultural factors related to adherence to imatinib in CML: A Mexican perspective

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2015, Hematology.